Revisiting Ocular Allergy: Evaluating Symptoms, Benzalkonium Chloride and Efficacy of Topical Ketotifen 0.025%. (17th February 2020)

• Record Type: Journal Article
• Authors: Boboridis, Kostas G.; Kozeis, Nikolaos; Konstas, Anastasios GP.
• Is Part Of: Ocular immunology and inflammation. Volume 28:Number 2(2020)
• Page Start: 188
• Page End: 190
• Publication Date: 2020-02-17
• Subjects: ketotifen -- allergy -- dry eye -- BAK -- benzalkonium -- preservatives -- MGD; Eye -- Diseases -- Immunological aspects -- Periodicals; Eye -- Inflammation -- Periodicals; 617.7
• DOI: 10.1080/09273948.2018.1560478
• Languages: English
• ISSNs: 0927-3948

Abstract

ABSTRACT: This interesting study raises a scientific issue for revisiting three important elements on diagnosis, use of preservatives and selection of the appropriate topical treatment. Itchy feeling can be encountered in other ophthalmic conditions misdiagnosed as allergy, benzalkonium chloride is responsible for surface toxicity resulting in reduced efficacy and tolerability of topical allergy medications and it should be avoided on the management of ocular allergy. Unpreserved ketotifen 0, 025% has been shown to be the least toxic formulation being the optimum option for efficacy and tolerability on the management of ocular allergy.